European Pharmaceutical Review

NOVEMBER 1, 2023

In July 2022, the World Health Organization (WHO) released its inaugural report on the pipeline of vaccines currently in development to prevent infections caused by antimicrobial resistance (AMR) bacterial pathogens. WHO referred to 61 bacterial vaccine candidates in diverse stages of clinical development. 1 WHO’s analysis was stark.

Vaccines 115

Vaccines Immunization 115

pharmaphorum

SEPTEMBER 22, 2022

Alexandre Le Vert, CEO and co-founder of Osivax, discusses the company’s breakthrough vaccine technology, oligoDOM, and how it’s driving the development of new influenza and SARS-CoV-2 vaccines that attack T-cells, providing a long-lasting effect. The technology.

Vaccines 97

Vaccines Immunization 97

European Pharmaceutical Review

DECEMBER 19, 2023

Many of today’s vaccines are produced in ready-to-inject liquid formulations that must be kept cold to maintain stability. However, this greatly complicates both the worldwide distribution and stockpiling of vaccines and other drugs. A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient.

Vaccines 111

Vaccines Communication Immunization Documentation 111

Hospital Pharmacy Europe

JANUARY 26, 2023

Despite HIV having been first discovered in 1983 , there are still no vaccines available against the virus. The vaccine used a common-cold virus (adenovirus serotype 26, Ad26) and was designed to deliver four antigens to illicit an immune response. Moreover, data shows that currently, across the world, there are approximately 1.5

Vaccines 98

Vaccines Immunization Hospitals 98

pharmaphorum

DECEMBER 6, 2022

5-adapted bivalent COVID-19 vaccine for children 6 months through 4 years of age to the FDA as a third 3-µg-dose in a three-dose-primary series, following two 3-µg-doses of the original vaccine. It is thought the updated vaccine might help to prevent severe illnesses and hospitalisation. 5-adapted bivalent vaccine.

Vaccines 105

Vaccines FDA Immunization 105

European Pharmaceutical Review

DECEMBER 12, 2023

He discusses why NK cell therapy’s ability to generate ‘synthetic immunity’ in the body means this modality holds potential as an anti-cancer treatment. We specialise in the development of new cutting-edge immunotherapies , based on the use of therapeutic antibodies capable of activating the immune system to fight cancer.

Immunization 124

Immunization Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 124

Pharmaceutical Technology

MAY 25, 2023

A new vaccine developed by the Serum Institute of India to fight meningococcal disease could help eliminate meningitis across Africa. The results from a trial, published in The New England Journal of Medicine , found the vaccine was associated with a strong immune response and good safety profile. for serogroup W to 20.5

Vaccines 78

Vaccines Immunization 78

BuzzRx

SEPTEMBER 12, 2022

There are two types of meningococcal vaccines available in the United States. Please keep reading to learn more about these vaccines, including their uses, benefits, and side effects. Meningococcal disease occurs when these bacteria overcome the body’s immune system and causes illnesses. What is meningococcal disease?

Vaccines 52

Vaccines Immunization 52

pharmaphorum

JUNE 15, 2022

Cytokines have long been investigated for their potential as cancer treatments – selectively stimulate tumour-fighting immune cells – with varying levels of success. The company came to Boehringer’s attention in 2019, when it took part in the drugmaker’s BI Innovation Prize competition.

Immunization 98

Immunization Vaccines 98

pharmaphorum

JANUARY 19, 2023

Prospects for Johnson & Johnson’s HIV vaccine effort have looked shaky since one of its shots failed to protect women in sub-Saharan Africa against infection with the virus in a phase 2b trial reported in 2021, and the company has now abandoned the programme altogether after a phase 3 readout.

Vaccines 52

Vaccines Immunization 52

The People's Pharmacy

MAY 29, 2023

The virus hides for decades and when the immune system is no longer able to keep it at bay the virus can cause an extremely painful skin rash that can last for weeks. When the immune system weakens, the virus can be reactivated and cause a rash. That is to say it can enhance the immune systems ability to fight off certain viruses.

Immunization 72

Immunization Labelling Pharmaceutical Companies Pharmaceutical Companies 72

pharmaphorum

OCTOBER 12, 2022

In 2019, Del Bourgo and co-founder Julien Cottineau launched Whitelab Genomics and its AI platform dedicated to supporting the discovery and design of genomic therapies. Del Bourgo highlights that genomic treatments work in a similar way to mRNA, which has been used in COVID-19 vaccines. About Whitelab Genomics.

Immunization 105

Immunization Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

JANUARY 13, 2022

Others include a partnership between Biogen and Sangamo and Eli Lilly’s $1 billion takeover of Prevail in 2020, as well as a now-defunct alliance between AbbVie and Voyager in 2019, based on gene therapy approaches to target the rogue protein.

Immunization 98

Immunization Vaccines 98

pharmaphorum

MARCH 9, 2021

SARS-CoV-2 is likely to stay endemic in the human population for the foreseeable future, ExeVir noted, with variants capable of evading immunity the most likely cause of the disease in the future as global vaccination programmes begin to take effect. Ablynx, which is now a subsidiary of Sanofi following a $4.8

Immunization 98

Immunization Vaccines FDA 98

pharmaphorum

FEBRUARY 25, 2021

The first trial showed that it could increase levels of Treg cells thought to be involved in dampening down immune responses. That includes deals to buy OncoImmune and its COVID-19 and GvHD candidate CD24Fc and COVID-19 vaccine developer Themis last year, and the $773 million takeover of Tilos Therapeutics in 2019.

Immunization 71

Immunization Vaccines 71

PharmaShots

MAY 23, 2023

Stock Exchange: TYO With focus areas extending to the discovery and development of biopharma products, AnGes is dedicated to developing genetic medicines and therapeutic vaccines for intractable or rare diseases. The company received its first approval from the Japanese government in 2019 to treat critical limb ischemia.

FDA 58

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 58

pharmaphorum

AUGUST 22, 2022

“Effectively, they create antibodies that can train one’s immune system to go after a specific cancer cell. ” Moderna has also created a personalised cancer vaccine, a similar idea where the vaccine is built against the specific cancer one has in the body. It could completely change how we treat cancers.”

Vaccines 102

Vaccines Chemotherapy Immunization 102

pharmaphorum

NOVEMBER 26, 2020

BioNTech may be deeply ensconced in the latter stages of its bid to bring a COVID-19 vaccine to market, but it’s still pushing forward on other fronts, including a partnership with InstaDeep to deploy artificial intelligence and machine learning across its business.

Vaccines 105

Vaccines Immunization 105

PharmaShots

MARCH 14, 2023

The act includes drugs, vaccines, and therapeutics that are intended to treat a disease affecting <200,000 American citizens. Stem Cell Therapy: Medically known as Hematopoietic stem cell transplantation (HSCT), the therapy involves the use of human cells to regulate the immune system.

FDA 40

FDA Immunization Compounding Vaccines 40

PharmaShots

APRIL 25, 2023

In 2019, Mallinckrodt entered into a collaboration agreement with Silence Therapeutics to develop and commercialize RNAi therapeutics to treat life-threatening unmet diseases. Through the 2019 agreement, Mallinckrodt received the exclusive worldwide license to Silence’s SLN500. R&D Expenditure: $6.6B

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Packaging Immunization Vaccines 40

pharmaphorum

JANUARY 10, 2023

Since then, the two partners have developed multiple AI-based applications including a platform for selecting neoantigens for use in individualised cancer vaccines and an early warning system for high risk SARS-CoV-2 variants based on how well they can evade the immune system and their transmissibility.

Immunization 116

Immunization Vaccines 116

European Pharmaceutical Review

DECEMBER 22, 2022

The success of mRNA vaccines against SARS-CoV-2 has quickly catapulted mRNA therapeutics as a disruptive, expanding drug category” The term ‘mRNA’ has become commonplace globally. The success of mRNA vaccines against SARS-CoV-2 has quickly catapulted mRNA therapeutics as a disruptive, expanding drug category.

Vaccines 116

Vaccines Immunization Hospitals 116

PharmaShots

MARCH 9, 2023

She has also been awarded Crain’s Notable Women in Healthcare in 2019. Birthplace: Belén was born in Almansa (Spain) Additional Information: Merck became a significant international participant in immunology, oncology, and immune oncology under her leadership of the Healthcare business. LinkedIn Total experience: 31 yrs.

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40

PharmaShots

FEBRUARY 21, 2023

Nordic is advancing the development of CD37-targeted therapies for hematological cancers and immune diseases. Under its cancer therapy products, the company develops low molecular drugs, antibody drugs, cancer peptide vaccines, and diagnostic medicines.

FDA 56

FDA Dosage Pharmaceutical Companies Pharmaceutical Companies 56

pharmaphorum

SEPTEMBER 22, 2021

Its lead project is a T-cell receptor (TCR)-like antibody against an HLA molecule associated with intracellular protein NKG2A, an immune checkpoint. Abexxa will form part of its broad push into immuno-oncology, focused on cancer vaccines, oncolytic viruses and T-cell engagers, amongst other treatment strategies.

Vaccines 92

Vaccines Immunization 92

PQA

AUGUST 8, 2022

Between 2019 and 2021, PQS has significantly contributed to the industry’s further understanding of how to utilize pharmacy as a clinical practice by helping to bring awareness of the impact pharmacy staff can have on their communities. Medicare Advantage–pharmacy partnership improves influenza and pneumococcal vaccination rates.

Independent Pharmacies 52

Independent Pharmacies Community Pharmacies Patient Care Vaccines 52

The Checkup by Singlecare

DECEMBER 26, 2023

It may occur in people over the age of 50 or people of any age with a compromised immune system. You can also get a vaccine called Shingrix to help reduce the risk of shingles infection if you are 50 or older—or if you are 19 or older with a higher risk of infection. VZV is the same virus that causes varicella, or chickenpox.

Immunization 52

Immunization Vaccines 52

pharmaphorum

JULY 6, 2021

Nina Garrett, R&D director at Abingdon Health discusses the key role antibody testing is playing in the pandemic and how an integrated approach with vaccines could help normal life resume. Millions of tests for COVID-19 are taken worldwide every day, as they become an increasingly important tool for our return to normality. ” . .

Immunization 111

Immunization Vaccines 111

European Pharmaceutical Review

SEPTEMBER 22, 2023

Active anti-Abeta immunotherapies In the 2000s, the concept of active immunotherapy targeting Abeta in Alzheimer’s patients was assessed with the ELAN vaccine (AN1792), consisting of full-length aggregated Abeta 1-42 peptide mixed with the QS21 adjuvant. 8 However, as this trial was not placebo-controlled, conclusions are difficult to draw.

Immunization 97

Immunization Vaccines Communication Labelling 97

PharmaShots

JANUARY 31, 2023

The company’s product portfolio comprises two platforms: Virax Immune, a new-Covid-19 test detecting the T-Cell immune response to the SARS-Cov-2 virus and ViraxClear, a platform to sell a range of highly accurate diagnostic test kits and machines. Founded Year: 2019 No. Founded Year: 2019 No. Funding Value: $7.7M

Vaccines 40

Vaccines Immunization FDA 40

Pharmaceutical Technology

FEBRUARY 14, 2023

The company offers a wide range of prescription drugs, over the counter (OTC) drugs, vaccines, and others. Besides cancer, the company’s other research areas include rare diseases and immune disorders. Daiichi Sankyo sells its products through its group companies, and an extensive network of medical representatives.

Immunization 40

Immunization Vaccines 40

The Checkup by Singlecare

MAY 23, 2024

There are lots of ways, from offering diabetes medication management sessions, immunizations, or even diabetes education for patients. A 2019 study aimed to assess whether a telephone-based pharmacist intervention could improve A1C in patients with poorly controlled diabetes through negotiated interviewing and shared decision-making.

Vaccines 52

Vaccines Immunization Medical Records Dosage 52

Pharmaceutical Technology

MARCH 2, 2023

is under development also treatment of pneumonia,coronavirus disease (2019). Merck overview Merck is a biopharmaceutical company focused on the discovery, development, manufacturing and marketing of prescription medicines, biologic therapies, vaccines and animal health products. It is administered through subcutaneous route.It

Chemotherapy 40

Chemotherapy FDA Vaccines Immunization 40

The Checkup by Singlecare

OCTOBER 6, 2023

Key takeaways: Methylprednisolone is an effective therapeutic agent to control immune responses and inflammation. Some interactions go beyond medications; certain foods can also affect methylprednisolone’s effectiveness.

Vaccines 52

Vaccines Mayo Clinic FDA Immunization 52

PQA

DECEMBER 15, 2022

Our work to develop pharmacy performance measures accelerated in 2019 at the request of PQA member organizations, especially community and specialty pharmacies, and in response to growing interest from Congress and the administration. Immunization Authority – PQA has prioritized pharmacy performance measure concepts related to immunizations.

Immunization 40

Immunization Vaccines Specialty Pharmacies Communication 40

The FDA Law Blog

JUNE 2, 2023

Penalties for “Misclassification” The Medicaid Services Investment and Accountability Act of 2019 added new penalties to the Medicaid rebate statute for knowingly misclassifying a covered outpatient drug. Vaccine”: Because vaccines are excluded from the MDRP, CMS proposes to define them solely for purposes of the MDRP.

Labelling 59

Labelling Vaccines FDA Immunization 59

pharmaphorum

DECEMBER 21, 2020

Moderna and BioNTech, two rising stars in biotech, were in the limelight this year with their pioneering mRNA vaccines against COVID-19. But the tragic events of 2020 have meant these companies have become household names as their trailblazing mRNA vaccines became the first to be approved by regulators against the COVID-19 scourge.

Vaccines 111

Vaccines Immunization 111